153 related articles for article (PubMed ID: 33218406)
1. Retinoic acid and fibroblast growth factor-2 play a key role on modulation of sex hormones and apoptosis in a mouse model of polycystic ovary syndrome induced by estradiol valerate.
Moayeri A; Rostamzadeh A; Raoofi A; Rezaie MJ; Abasian Z; Ahmadi R
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):882-890. PubMed ID: 33218406
[TBL] [Abstract][Full Text] [Related]
2. All-trans retinoic acid and fibroblast growth factor-2 enhance the fertility rate and embryo development in polycystic ovary syndrome mouse model.
Rustamzadeh A; Anjomshoa M; Bahreini N; Darabi S; Rezaie MJ; Rezaei S; Rahimi-Madiseh M; Deris F; Zamani S
Iran J Basic Med Sci; 2024; 27(4):418-424. PubMed ID: 38419892
[TBL] [Abstract][Full Text] [Related]
3. Effect of 150 kHz electromagnetic radiation on the development of polycystic ovaries induced by estradiol Valerate in Sprague Dawley rats.
Mohammed S; Sundaram V; Zyuzikov N
J Ovarian Res; 2021 Feb; 14(1):26. PubMed ID: 33546719
[TBL] [Abstract][Full Text] [Related]
4. Improvement of the folliculogenesis by transplantation of bone marrow mesenchymal stromal cells in mice with induced polycystic ovary syndrome.
Kalhori Z; Azadbakht M; Soleimani Mehranjani M; Shariatzadeh MA
Cytotherapy; 2018 Dec; 20(12):1445-1458. PubMed ID: 30523787
[TBL] [Abstract][Full Text] [Related]
5. L-Carnitine improves endocrine function and folliculogenesis by reducing inflammation, oxidative stress and apoptosis in mice following induction of polycystic ovary syndrome.
Kalhori Z; Mehranjani MS; Azadbakht M; Shariatzadeh MA
Reprod Fertil Dev; 2019 Jan; 31(2):282-293. PubMed ID: 31039949
[TBL] [Abstract][Full Text] [Related]
6. An investigation of the potential effects of amitriptyline on polycystic ovary syndrome induced by estradiol valerate.
Alkan I; Kaplan S
Histochem Cell Biol; 2023 Jul; 160(1):27-37. PubMed ID: 36971834
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome.
Tessaro I; Modina SC; Franciosi F; Sivelli G; Terzaghi L; Lodde V; Luciano AM
J Ovarian Res; 2015 Oct; 8():64. PubMed ID: 26437930
[TBL] [Abstract][Full Text] [Related]
8. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.
Pascuali N; Scotti L; Di Pietro M; Oubiña G; Bas D; May M; Gómez Muñoz A; Cuasnicú PS; Cohen DJ; Tesone M; Abramovich D; Parborell F
Hum Reprod; 2018 May; 33(5):844-859. PubMed ID: 29534229
[TBL] [Abstract][Full Text] [Related]
9. The effect of ellagic acid on sex hormones and miRNA-21 expression in rats with polycystic ovary syndrome.
Khoshvaghti A; Rahbari R
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4263-4273. PubMed ID: 38078918
[TBL] [Abstract][Full Text] [Related]
10. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
11. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
12. The significant improvement in ovarian PCOS syndrome using hydralazine and alendronate aromatase inhibitor FDA-approved drugs in Wistar rat models.
Kavousipour S; Koohnavard F; Shahbazi B; Eftekhar E; Ahmadi K
Biomed Pharmacother; 2024 May; 174():116504. PubMed ID: 38552442
[TBL] [Abstract][Full Text] [Related]
13. Effect of microRNA-409 on the pathogenesis of polycystic ovary syndrome.
Teng YL; Lin SY; Yang HY; Meng LH; Yu R; Zeng LC
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1874-1881. PubMed ID: 30915729
[TBL] [Abstract][Full Text] [Related]
14. Isorhamnetin inhibits inflammatory response to alleviate DHEA-induced polycystic ovary syndrome in rats.
Yu F; Xue Y; Zhao Y; Zhang L; He X; Liu Z
Gynecol Endocrinol; 2023 Dec; 39(1):2183045. PubMed ID: 36842967
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of minocycline on the ovary of polycystic ovary syndrome mouse model: Molecular docking analysis and evaluation of TNF-α, TNFR2, TLR-4 gene expression.
Khajouei A; Hosseini E; Abdizadeh T; Kian M; Ghasemi S
J Reprod Immunol; 2021 Apr; 144():103289. PubMed ID: 33610928
[TBL] [Abstract][Full Text] [Related]
16. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
[TBL] [Abstract][Full Text] [Related]
17. Does metformin improve in vitro maturation and ultrastructure of oocytes retrieved from estradiol valerate polycystic ovary syndrome-induced rats.
Mesbah F; Moslem M; Vojdani Z; Mirkhani H
J Ovarian Res; 2015 Nov; 8():74. PubMed ID: 26577050
[TBL] [Abstract][Full Text] [Related]
18. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation.
Anderson RA; Groome NP; Baird DT
Clin Endocrinol (Oxf); 1998 May; 48(5):577-84. PubMed ID: 9666869
[TBL] [Abstract][Full Text] [Related]
19. Alteration in angiogenic potential of granulosa-lutein cells and follicular fluid contributes to luteal defects in polycystic ovary syndrome.
Patil K; Hinduja I; Mukherjee S
Hum Reprod; 2021 Mar; 36(4):1052-1064. PubMed ID: 33377483
[TBL] [Abstract][Full Text] [Related]
20. Activation of TGF-β1/Smad3 signaling pathway inhibits the development of ovarian follicle in polycystic ovary syndrome by promoting apoptosis of granulosa cells.
Shen H; Wang Y
J Cell Physiol; 2019 Jul; 234(7):11976-11985. PubMed ID: 30536903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
